Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2001-04-24 | MITCHEL SAYARE, PH.D. (Age: 53, Director Since: September 1994) is a member of the Compensation and Stock Option, the Audit and the Nominating Committees of the Board of Directors. ... Its members are Messrs. Cashen, Maxwell and Sayare. The Compensation and Stock Option Committee held three meetings during 2000. ... The Board's Audit Committee ... Its members are Drs. Maxwell and Sayare. The Audit Committee held two meetings during 2000. ... The Board's Nominating Committee ... Its members are Messrs. Haffer, Maxwell and Sayare. The Nominating Committee met once during 2000. ... Mr. Cashen, Dr. Haffer, Dr. Maxwell and Dr. Sayare each received $6,000 and Dr. Donahoe received $3,000 during 2000 for their attendance and services at regular meetings of the Board of Directors and for the $2,000 annual retainer fee. |
| 2002-04-29 | MITCHEL SAYARE, PH.D. (Age: 54, Director Since: September 1994) is a member of the Compensation and Stock Option, the Audit and the Nominating Committees of the Board of Directors. ... Dr. Sayare received $5,250 during 2001 for their attendance and services at regular meetings of the Board of Directors and for the annual retainer fee. |
| 2003-04-29 | MITCHEL SAYARE, Ph.D. (Age: 55, Director Since: September 1994) is a member of the Compensation and Stock Option, the Audit and the Nominating Committees of the Board of Directors. ... Messrs. Cashen, Rothschild and Sayare each received $6,000 during 2002 for their attendance and services at regular meetings of the Board of Directors and for the annual retainer fee. |
| 2004-04-16 | MITCHEL SAYARE, Ph.D. (Age: 56, Director Since: September 1994) is a member of the Compensation and Stock Option, the Audit and the Nominating Committees of the Board of Directors. Dr. Sayare joined ImmunoGen Inc., a biotechnology company, (ImmunoGen) in 1986 as President and Chief Executive Officer and is currently ImmunoGens Chairman, President and Chief Executive Officer. From 1982 to 1985 Dr. Sayare was Vice President of Development at Xenogen, Inc., a biotechnology company, and from 1977 to 1982 he was Assistant Professor of Biochemistry at the University of Connecticut. |
| 2005-04-19 | MITCHEL SAYARE, Ph.D. (Age: 57, Director Since: September 1994) is a member of the Compensation and Stock Option, the Audit and the Nominating Committees of the Board of Directors. Dr. Sayare joined ImmunoGen Inc., a biotechnology company, (ImmunoGen) in 1986 as President and Chief Executive Officer and is currently ImmunoGens Chairman, President and Chief Executive Officer. |
| 2006-04-21 | MITCHEL SAYARE, Ph.D. (Age: 58, Director since: September 1994) is chairman of the Audit Committee and a member of the Compensation and Stock Option and Nominating Committees of the Board of Directors. |
| 2007-04-17 | MITCHEL SAYARE, Ph.D. (Age: 59, Director since: September 1994) is chair of the Audit Committee and a member of the Compensation and Stock Option Committee and the Nominating Committee of the Board of Directors. ... Mitchel Sayare, Ph.D. Fees Earned or Paid in Cash: $5,000, Total: $5,000. |
Data sourced from SEC filings. Last updated: 2026-02-03